Welcome to our dedicated page for TD SYNNEX CORPORATION SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for TD SYNNEX Corporation (NYSE: SNX), a global distributor and solutions aggregator for the IT ecosystem. Through these filings, investors can review the company’s official disclosures on financial performance, capital structure, governance and material events.
TD SYNNEX uses current reports on Form 8-K to announce items such as quarterly financial results, dividend declarations, executive leadership changes and financing activities. For example, recent 8-K filings describe fiscal quarter earnings releases furnished under Item 2.02, the declaration of cash dividends on common stock, and the issuance of senior notes due 2029 and 2035, including key terms and intended uses of proceeds.
Alongside 8-Ks, investors can consult annual reports on Form 10-K and quarterly reports on Form 10-Q (where available in the feed) for more detailed discussions of TD SYNNEX’s business, risk factors, segment information and financial statements. These core filings are complemented by other documents such as registration statements and prospectus supplements referenced in connection with debt offerings.
On Stock Titan, TD SYNNEX filings are updated in near real time from the SEC’s EDGAR system. AI-powered tools help summarize lengthy documents, highlight key sections and clarify non-GAAP metrics the company uses, such as non-GAAP gross billings, non-GAAP operating income, non-GAAP net income, non-GAAP diluted EPS, Adjusted EBITDA, free cash flow and adjusted return on invested capital. Users can also review disclosures related to executive appointments, compensation arrangements and other governance matters reported under Item 5.02 of Form 8-K.
Together, these filings offer a structured view of how TD SYNNEX reports its financial condition, capital markets activity and corporate developments to regulators and investors.
TD SYNNEX director Ann Vezina reported a sale of 812 shares of TD SYNNEX common stock on 08/13/2025 at $150.42 per share, as disclosed on a Form 4. The filing shows 6,079 shares remain beneficially owned directly after the transaction.
The Form 4 lists the transaction code as S (sale) and is signed by an attorney-in-fact.
TD SYNNEX Corporation submitted a Rule 144 notice reporting a proposed sale of 812 common shares through Raymond James & Associates on the NYSE with an aggregate market value of $122,189 and an approximate sale date of 08/13/2025. The filing lists 82,467,079 shares outstanding.
The securities to be sold were acquired as stock grants on 02/28/2022 (364 shares) and 08/31/2022 (448 shares). The form reports no securities sold in the past three months and includes the signer’s representation that they do not know of any material nonpublic information.
TD SYNNEX CFO Witt Marshall reported transactions on 08/11/2025 showing both an acquisition and a sale of 862 common shares. The filing records an acquisition at a per-share price of $57.34 and a contemporaneous sale at $146.39, leaving the reporting person with 49,777 shares beneficially owned after the sale (the filing also shows 50,639 shares following the acquisition prior to the sale). The filing discloses ownership of 9,471 employee stock options following the reported transactions and notes that the sales were made pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2025.
The Form 4 includes an employee stock option entry with a conversion/exercise price of $57.34 for 862 underlying shares and describes the option vesting schedule. The report is signed on behalf of the reporting person by an attorney-in-fact on 08/12/2025.
TD SYNNEX (SNX) insider notice to sell 3,445 common shares. The Form 144 shows 3,445 shares offered through Morgan Stanley Smith Barney with an aggregate market value of $504,933.65, representing approximately 0.0042% of 82,467,079 outstanding shares. The shares were acquired and paid for on 08/11/2025 by exercise of stock options and the planned sale is listed for the same date.
The filing also records prior 10b5-1 sales by the same person of 1,509 shares on 06/18/2025 that generated $189,148.32 in gross proceeds. The notice includes the standard insider representation that no material nonpublic information is known to the seller.
The Vanguard Group has filed Amendment No. 3 to Schedule 13G for TD SYNNEX Corporation (SNX). As of 31 Jul 2025 the asset manager beneficially owns 8,274,403 common shares, representing 10.03 % of the outstanding class.
- Sole voting power: 0 shares
- Shared voting power: 461,300 shares
- Sole dispositive power: 7,718,714 shares
- Shared dispositive power: 555,689 shares
The filing, made under Rule 13d-1(b), classifies Vanguard as an investment adviser (IA). Vanguard affirms the shares were acquired in the ordinary course of business and not to influence control. Crossing the 10 % threshold designates Vanguard as a significant passive holder, potentially enhancing liquidity and governance attention but implying no immediate strategic change.
Form 4 filed for TD SYNNEX (SNX) by Dennis Polk. The filing reports insider sales on 08/04/2025 executed pursuant to a Rule 10b5-1 trading plan adopted October 13, 2024 on behalf of the Polk family trust.
- Sales: 300 shares at a weighted-average price of $141.82 and 2,700 shares at a weighted-average price of $142.22.
- Beneficial ownership reported after the transactions: 90,360 and 87,660 shares, held indirectly "By Trust."
- Form signed by /s/ Cheryl Grant, attorney-in-fact on 08/05/2025.
The form also contains an additional Table I entry showing 35,295 with a disposition indicator "D" but lacking accompanying date, price or ownership columns in the provided excerpt.
FAQ
What is the current stock price of TD SYNNEX CORPORATION (SNX)?
What is the market cap of TD SYNNEX CORPORATION (SNX)?
